Investors
Strategy aiming for strong and profitable growth
The strategy aims for strong and profitable growth, based on organic growth enabled by the market and carefully considered acquisitions. Through active development, Biohit has turned its operations to profitable growth over the past years.
Biohit – Innovating for Health
Biohit promotes people's health with its innovative products. The company's product portfolio includes diagnostic products for gastrointestinal diseases and carcinogenic acetaldehyde binding products. The products have a global and growing market, and approximately 98 per cent of the company’s production is exported. The most significant potential lies in the GastroPanel® product range that is used for testing gastric health. The ageing of the population, scarce healthcare resources and the simultaneously increasing prevalence of gastrointestinal diseases require more cost-effective diagnosis of diseases and easier screening for cancer risks. Biohit's innovations meet these challenges.
Financial targets
Biohit's financial targets for the strategy period 2024–2028:
Growth
Revenue growth 15–20% annually
Profitability
Operating profit (EBIT) at least 10% of revenue
Priorities and actions of the strategy
Continuing the innovation legacy of the expert of the gastrointestinal tract
Strengthening competitive edge by developing business operations and investing in product development while understanding the laws of health technology. Strengthening cooperation with industry, research institutes, universities, hospitals and laboratories.
Expanding the markets
Presence in all relevant markets, either through own subsidiaries or through local sales representatives. Ensuring high quality of the distributor network and digital channels.
Completing the product range
Dynamic modification of the product range based on customer needs.
Active selling
Strengthening customer understanding, better identifying their needs and providing tailored, value-added solutions. A systematic order-to-supply chain.
A company that attracts investors and talent
Strengthening the reputation of a profitably growing health technology company through an active IR policy and through providing excellent development opportunities for new talent.
© BIOHIT Healthcare Oyj